Expansion opportunities IMA has a history of strategic acquisitions expanding into psychiatry, neurology, and disability evaluation capabilities across multiple states, signaling ongoing capacity for growth and cross-sell of clinical research services, evaluation services, and payer partnerships.

Clinical research network With a nationwide multi-site clinical research network and recent acquisitions of CRC and Medical Research Network, there is strong potential to partner with pharmaceutical and biotech firms seeking scalable Phase II–IV trial sites and CNS-focused studies.

Government and payer reach IMA’s Evaluation Services for federal, state, and local governments and commercial payers creates opportunities to expand risk-based contracts, payer value solutions, and compliance-driven services for health plans, employers, and workers’ compensation programs.

Leadership and growth Recent leadership appointments in sales and a track record of enterprise growth indicate a client-focused go-to-market strategy, suggesting potential for upsell of enterprise evaluation contracts, site networks, and strategic clinical trial partnerships.

Technology enablement Leveraging iCIMS, Tableau, AWS, and other tools supports scalable recruiting, data analytics, and secure trial operations, presenting sales angles around improved study site performance, data integration, and streamlined government/payer reporting for prospective customers.